Previous Section
General Interest Articles
28. Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).
- Author
- Medeiros BC; Minden MD; Schuh AC; Schimmer AD; Yee K; Lipton JH; Messner HA; Gupta V; Chun K; Xu W; Das P; Kamel-Reid S; Brandwein JM;
- Institution
- Department of Medical Oncology, Peincess Margaret Hospital, University Health Network, Univeristy of Toronto, Toronto, Ontario, Canada.
- Journal
- Leuk Lymphoma. 2007 Jan;48(1):65-71.
- Abstract URL
- Click here to view abstract
29. Targeted agents in AML: much more to do.
- Author
- Stone RM;
- Institution
- Adult Leukemia Program, Dana Farber Cancer Institute and Harvard Medical School, 44 Binney Street, D 840 Boston, MA 02115, USA. rstone@partners.org
- Journal
- Best Pract Res Clin Haematol. 2007 Mar;20(1):39-48.
- Abstract URL
- Click here to view abstract
30. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
- Author
- Larson RA;
- Institution
- Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois 60637, USA. rlarson@medicine.bsd.uchicago.edu
- Journal
- Best Pract Res Clin Haematol. 2007 Mar;20(1):29-37.
- Abstract URL
- Click here to view abstract
31. Long-term follow-up of Asian patients younger than 46 years with acute myeloid leukemia in first complete remission: comparison of allogeneic vs. autologous hematopoietic stem cell transplantation.
- Author
- Loh YS; Koh LP; Tai BC; Hwang WY; Linn YC; Goh YT; Tan PH;
- Institution
- Department of Haematology, Singapore General Hospital, Singapore. yvonne.loh.s.m@sgh.com.sg
- Journal
- Leuk Lymphoma. 2007 Jan;48(1):72-9.
- Abstract URL
- Click here to view abstract
Next: Drug Therapy
